New observations on factor XI deficiency

Haemophilia, Supplement

Volumn 10, Issue 4, 2004, Pages 184-187

  Salomon, Ophiras ^a   Seligsohn, U ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bleeding; Factor XI; Inhibitors; Recombinant factor VIIa

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR CONCENTRATE; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; TRANEXAMIC ACID;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BLEEDING DISORDER; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CARDIOVASCULAR DISEASE; CLINICAL OBSERVATION; DISEASE SEVERITY; GENE MUTATION; HEART INFARCTION; HEMOPHILIA; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IRAQ; ISRAEL; JEW; MISSENSE MUTATION; MUTATIONAL ANALYSIS; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; THROMBOSIS; UNITED KINGDOM;

EID: 11044235063     PISSN: 13550691     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2004.00992.x     Document Type: Article

References (25)

1. Gailani D, Broze GJ. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-12.
2. Gailani D, Ho D, Sun MF, Cheng Q, Walsh PN. Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential. Blood 2001; 97: 3117-22.
3. von dem Borne PAK, Meijers JCM, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 1995; 86: 3035-42.
4. Kato A, Asakai R, Davie EW, Aoki N. Factor XI gene (F11) is located on the distal end of the long arm of human chromosome 4. Cytogenet Cell Genet 1989; 52: 77-8.
5. Seligsohn U, Modan M. Definition of the population at risk of bleeding due to factor XI deficiency in Ashkenazi Jews and the value of the activated partial thromboplastin time in its detection. Israel J Med Sci 1981; 17: 413-5.
6. Seligsohn U. Factor XI deficiency. Thromb Hemost 1993; 70: 68-71.
7. Peyvandi F, Lak M, Mannucci PM. Factor XI deficiency in Iranians. its clinical manifestations in comparison to those of classic hemophilia. Haematologica 2002; 87: 512-4.
8. Bolton-Maggs PH, Patterson DA, Wensley RT, Tuddenham EG. Definition of the bleeding tendency in factor XI-deficient kindreds-a clinical and laboratory study. Thromb Haemost 1995; 73: 194-202.
9. Sidi A, Seligsohn U, Jonas P, Many M. Factor XI deficiency. detection and management during urological surgery. J Urol 1978; 119: 528-30.
10. Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991; 325 153-8.
11. Shpilberg O, Peretz H, Zivelin A et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood 199S; 85: 429-32.
12. Zivelin A, Bauduer F, Ducout L, et al. Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood 2002; 99: 2448-54.
13. Bolton-Maggs Peretz H, Butler R, Mountford R et al. A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency. J Thromb Haemost 2004; 2 1-7.
14. Kravtsov D, Wu W, Meijers JC et al. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood 2004; 104: 128-34.
15. Salomon O, Steinberg DM, Dardik R et al. Inherited factor X1 deficiency confers no protection against acute myocardial infarction. J Thromb Haemost 2003; 1: 658-61.
16. Meijers JC, Tekelemburg WL, Bouma BN, Bettina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342: 696-701.
17. Brodsky JB, Burgess GE III Pulmonary embolism with factor XI deficiency. JAMA 1975; 1156: 234-7.
18. Salomon O, Zivelin A, Livnat T et al. Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency. Blood 2003; 101: 4783-8.
19. Bolton-Maggs PHB. Factor XI deficiency and its management. Haemophilia 2000; 6: 100-9.
20. Salomon O, Steinberg DM, Tamarin I, Zivelin A, Seligsohn U. Plasma replacement therapy during labour is not mandatory for women with severe factor XI deficiency. Blood Coagul Fibrinol; in press.
21. Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003; 29: 125-30.
22. Berliner S, Horowitz I, Martinowitz U, Brenner B, Seligsohn U. Dental surgery in patients with severe factor XI deficiency without plasma replacement therapy. Blood Coagul Fibrinol 1992; 3: 465-8.
23. David AL, Paterson-Brown S, Letsky A. Factor XI deficiency presenting in pregnancy. diagnosis and management. Br J Obstet Gynaecol 2002; 109: 840-3.
24. Lawler P, White B, Pye S et al. Successful use of recombinant factor VIIa in patients with inhibitor secondary to severe factor XI deficiency. Haemophilia 2002; 8: 145-8.
25. Hender U. Factor VIIa in the treatment of haemophilia. Blood Coagul Fibrinol 1990; 1: 307-17.